TR200200506T2 - Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem - Google Patents

Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Info

Publication number
TR200200506T2
TR200200506T2 TR2002/00506T TR200200506T TR200200506T2 TR 200200506 T2 TR200200506 T2 TR 200200506T2 TR 2002/00506 T TR2002/00506 T TR 2002/00506T TR 200200506 T TR200200506 T TR 200200506T TR 200200506 T2 TR200200506 T2 TR 200200506T2
Authority
TR
Turkey
Prior art keywords
production
clusters
telithromycin
spherical
spherical telithromycin
Prior art date
Application number
TR2002/00506T
Other languages
English (en)
Inventor
Godard Jean-Yves
Rognon - Ravaux Val�Rie
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200200506(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of TR200200506T2 publication Critical patent/TR200200506T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Bulus küre seklinde telitromisin kümeleri ve bunlarin üretimi için bir yöntem ile ilgilidir ki söz konusu yöntem su sekilde karakterize edilir: bir telitromisin kristal süspansiyonu hazirlanir, söz konusu kristaller, kademeli olarak kristalize olan erimez bir telitromisin fazi ile kaplanir. Küre seklinde telitromisin kümeleri mikro-kapsüllerin hazirlanmasinda kullanilir.
TR2002/00506T 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem TR200200506T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
TR200200506T2 true TR200200506T2 (tr) 2002-08-21

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00506T TR200200506T2 (tr) 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Country Status (34)

Country Link
US (1) US6825218B1 (tr)
EP (1) EP1212336B1 (tr)
JP (1) JP4871467B2 (tr)
KR (1) KR100718222B1 (tr)
CN (1) CN1183151C (tr)
AR (1) AR025398A1 (tr)
AT (1) ATE255590T1 (tr)
AU (1) AU774385B2 (tr)
BR (1) BR0013569B1 (tr)
CA (1) CA2382497C (tr)
CO (1) CO5190666A1 (tr)
CZ (1) CZ2002594A3 (tr)
DE (1) DE60006976T2 (tr)
DK (1) DK1212336T3 (tr)
EA (1) EA005080B1 (tr)
ES (1) ES2209970T3 (tr)
FR (1) FR2797875B1 (tr)
HK (1) HK1049167B (tr)
HR (1) HRP20020167B1 (tr)
HU (1) HU229075B1 (tr)
IL (2) IL148128A0 (tr)
ME (2) MEP20108A (tr)
MX (1) MXPA02001988A (tr)
NO (1) NO322622B1 (tr)
PL (1) PL204100B1 (tr)
PT (1) PT1212336E (tr)
RS (1) RS50433B (tr)
SI (1) SI1212336T1 (tr)
SK (1) SK287588B6 (tr)
TR (1) TR200200506T2 (tr)
TW (1) TWI272949B (tr)
UA (1) UA73523C2 (tr)
WO (1) WO2001014393A2 (tr)
ZA (1) ZA200201599B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (fr) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (uk) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
MEP20108A (en) 2010-06-10
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (fr) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
YU13202A (sh) 2004-09-03
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
EA200200294A1 (ru) 2002-08-29
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
DK1212336T3 (da) 2004-03-15
ME00112B (me) 2010-10-10
NO20020926L (no) 2002-02-26
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
TR200200506T2 (tr) Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem
DK1255534T3 (da) Fremgangsmåde til fremstilling af mikrokugler, der indeholder kolloide systemer
NO20043209L (no) Fremstilling av A9 tetrahydrocannabinol
WO2001034835A3 (en) Method for the production of biopolymers with modified properties
ID22536A (id) Garam amina kristal dari cefdinir
DK1483390T3 (da) Transgene planter, der syntetiserer stivelse med höjt amyloseindhold
DE69923566D1 (de) Gelbeschichtete mikrokapseln
AT504347B8 (de) Verfahren zur herstellung von glucosederivaten
TR200001472T2 (tr) 8-metoksi-kuinolon-karboksilik asitlerin hazırlanması için yöntem
NO20010516L (no) Krystallmodifisering av liponsyre
NO995114L (no) Festeanordning for å forbinde to deler med hverandre, samt anvendelse av festeanordningen
ATE223919T1 (de) Ionische flüssigkeiten, ihre herstellung und ihre verwendung
NO305552B1 (no) Fluorfenylsubstituerte alkenylkarboksylsyre-guanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum sÕvel som medikament inneholdende dem
JP7170989B2 (ja) 酵素固定化用担体および固定化酵素
NO985029D0 (no) Forbedring av, eller med hensyn til, synkronisering
ES2079078T3 (es) Procedimiento para producir glucosa y fructosa a partir de sacarosa.
WO2003014428A3 (fr) Procede d'obtention d'un monocristal de cdte ou de cdznte, et monocristal obtenu par ce procede
AU2001248797A1 (en) Optically active quaternary ammonium salt with axial asymmetry, process for producing the same, and application to asymmetric synthesis of alpha-amino acid derivative
MX9300481A (es) Variedad mutante de maiz y metodo para su produccion.
CA2000155A1 (en) Production of pigment compositions
EP1277755A4 (en) OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT BY AXIAL ASYMMETRY, METHOD FOR THE PRODUCTION THEREOF, AND THEIR APPLICATION IN THE ASYMMETRIC SYNTHESIS OF ALPHA-AMINO-ACID DERIVATIVES
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen
TR200101388T2 (tr) Yeni pirimidin türevleri ve bunları hazırlama prosesleri
WO2000047723A3 (en) Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
CN102584926A (zh) 利用基于胆固醇和磷酸胆碱两亲小分子制备超分子水凝胶的方法